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 34 
The reactions of dinuclear [Pt2(4-RC6H4)4(μ-SEt2)2] (R = Me or F), or mononuclear [Pt(4-35 
RC6H4)2(SMe2)2] (R = Me or H), platinum(II) compounds with imines of the general formula 2-X,6-36 
YC6H3CHvNCH2Ph (X = Br, Y = F; X = Cl, Y = F; X = Br, Y = H) produced seven-membered [C,N]-37 
platinacycles. The reaction consists of the initial formation of cyclometallated platinum(IV) compounds 38 
followed by a three step process: reductive elimination, isomerisation of the resulting non-39 
cyclometallated intermediate and a final cycloplatination process. Combined 1H NMR and UV-Vis 40 
kinetico-mechanistic studies indicated that the rate determining step of the process depends on the nature 41 
of the aryl-Pt ligand (phenyl, p-tolyl or p-fluorophenyl). 42 
 43 
  44 
INTRODUCTION 45 
 46 
Cyclometallated platinum compounds containing N-donor ligands have attracted a great deal of interest 47 
due to their applications in several areas.1 In particular, cycloplatinated compounds with fluoro 48 
substituents are involved in fundamental processes of organometallic chemistry,2 in platinumcatalyzed 49 
cross coupling reaction of aryl fluorides3–6 and in the design of efficient light emitting devices.7,8 50 
Moreover, the presence of fluoro substituents can be decisive in the regioselectivities and rates of 51 
metallacycle formation.9,10 52 
In recent years, a novel class of seven-membered terdentate [C,Nimine,Namine] or bidentate [C,Nimine] 53 
platinacycles containing biaryl moieties has been reported.11–15 The mechanism of formation of this 54 
type of terdentate [C,Nimine,Namine] compounds has been carefully studied, including the isolation of 55 
several intermediates.16 As shown in Scheme 1, the initial step of the complete process corresponds to 56 
the formation of cyclometallated platinum(IV) compounds through intramolecular C–Br or C–Cl bond 57 
activation of the ligand at the platinum precursor. This step is followed by C–C bond formation via 58 
reductive elimination, involving one of the aryl ancillary ligands and the metallated aryl ring; 59 
isomerization of the resulting species and a final cyclometallation of the biaryl fragment result in the 60 
final cyclometallated complex. In the last step, the formation of seven-membered platinacycles is 61 
favoured over the formation of five-membered analogues for X = Cl. Moreover, the presence of a 62 
fluorine substituent (Y = F) at the ortho position, on the initially cyclometallated ligand, inhibits the 63 
formation of a five-membered platinacycle, thus favouring the seven-membered cycloplatination. Since 64 
the analogous bidentate [C,Nimine] seven-membered platinacycles have received less attention so far, 65 
we decided to undertake a study on the synthesis and mechanism for this class of compounds. With this 66 
aim the reactions of dinuclear [Pt2(4-RC6H4)4(μ-SEt2)2] (R = Me or F), or mononuclear [Pt(4-67 
RC6H4)2(SMe2)2] (R = Me or H), organoplatinum(II) compounds with imines of the general formula 68 
2-X,6-YC6H3CHvNCH2Ph (X = Br, Y = F; X = Cl, Y = F; X = Br, Y = H) were tested. In these 69 
systems, the role of the ancillary neutral (SEt2 or SMe2) ligands, as well as the substituents on the aryl 70 
(R = F, Me, H) ligands of the platinum precursor will be analysed both from a synthetic and a kinetico-71 
mechanistic perspective. 72 
  73 
RESULTS AND DISCUSSION 74 
 75 
Preparation of seven-membered platinacycles 76 
The general preparation procedure for the seven-membered cycloplatinated compounds studied is 77 
outlined in Scheme 2. Reactions of the corresponding platinum precursor and imine were carried out in 78 
refluxing toluene for six hours and produced the new seven-membered platinum(II) cyclometallated 79 
compounds 71-MeBrF, 71-MeClF, 71-FBrF, 71-FClF, 72-MeBrF, 72-MeBrH, and 72-HBrF as 80 
indicated. The uniform nature of the final products thus prepared, as well as the obtained yields (all 81 
within the 60–85% range), suggests that the reaction sequence is independent of the nature of the 82 
platinum compound and the imine ligand used. This result is in interesting contrast with the results 83 
obtained for the reaction of [Pt2(4-MeC6H4)4(μ-SEt2)2] with imines 2-XC6H4CHvNCH2CH2NMe2 84 
where the formation of seven- and five-membered platinacycles is preferred for X = Cl and X = Br, 85 
respectively.16,17 NMR data obtained for these compounds are consistent with the proposed structures. 86 
Both the imine proton ( JH–Pt in the 120–128 Hz range) and the Ha proton adjacent to the metalation 87 
site ( JH–Pt in the 52–65 Hz range) are coupled with 195Pt. The latter signal appears as a singlet for 71-88 
MeBrF, 71-MeClF, 72-MeBrF and 72-MeBrH, as a doublet ( JH–F = 9.2) for 71-FBrF and 71-FClF, or 89 
as a doublet of doublets ( JH–H = 7.6 and 1.2) for 72-HBrF, in agreement with the presence of a methyl, 90 
a fluoro or a hydrogen atom in ortho to Ha respectively. 91 
Compound 71-MeBrF was also characterised crystallographically (Fig. 1); the molecular structure 92 
confirms the formation of a biaryl linkage producing a non-planar seven-membered platinacycle. As for 93 
previously reported analogous structures, 13,15 the metallated aryl ring is in a trans disposition to the 94 
bromo ligand, while the nitrogen donor atom is situated trans to the SEt2 ancillary ligand. Bond lengths 95 
and angles are well within the range of values obtained for cyclometallated compounds, as indicated in 96 
Fig. 1. 97 
 98 
Kinetico-mechanistic study 99 
Given the fact that the general (5 → 7) sequence shown in Scheme 2 has been found to be very finely 100 
tuned by the presence of different substituents on the initial cyclometallating ligand, 3,16–18 a detailed 101 
mechanistic study has been conducted for the present system. The different steps involved in the full 102 
preparative process indicated have been often studied from a kinetico-mechanistic perspective.14,15,19 103 
The behaviour is well-established for the initial oxidative addition reactions (4 → 5),10,20–24 as well as 104 
for the reductive elimination/oxidative addition follow up processes (5 → 7).16–18 From the data 105 
collected so far in the literature, it is clear that, despite the relative formal simplicity of the reactivity 106 
observed, the general mechanism is a compendium of multistep processes that include fast 107 
coordination/decoordination equilibria21,23,24 and isomerization reactions.16,17 Scheme 3 collects the 108 
kineticomechanistic sequential steps expected for the process. 109 
For this purpose, complexes 5 were obtained from the reaction of 1 + 3 on a small scale; after workup 110 
the complexes were found to be of a high enough purity to study the 5 → 7 reaction without the 111 
presence of any remaining 1 or 3 species in solution. Nevertheless, in most of the cases some 1H NMR 112 
signals are also evident, which were assigned to some amounts of complex 6 as described in the 113 
Experimental part, their intensity increasing on workup as expected (see below). The detailed 1H NMR 114 
monitoring of the 5 → 7 reaction in CDCl3 solution was then conducted to ascertain the relative 115 
readiness of the 5 → 6 and 6 → 7 steps, as well as possible isomerisation processes of compounds 6, 116 
already observed for similar systems.16,17 117 
In all cases the initial 1H NMR spectra indicate the presence of two isomeric forms of compounds 5 in a 118 
2 : 1 ratio, characterised by a JH–Pt value for the imine proton within the 44–48 Hz range. These forms 119 
can be associated with the relative positions of the L and X ligands in the structure (Scheme 3). This 120 
isomeric distribution has already been observed for complexes of the same family,25,26 even the 121 
isomerization on substitution of the dialkylsulfide by phosphine has been quantified, as well as the 122 
formation of dimeric species.25,27 Scrambling between these two isomeric forms is known to be fast on 123 
the NMR time-scale for the bis-methyl analogue of 52-HBrH and, consequently, should not be relevant 124 
to the follow up 5 → 6 reductive elimination.26 Effectively the disappearance of the two isomers of 125 
species 5 occurs simultaneously, indicating its rapid scrambling. From this point the appearance of two 126 
reductive eliminated forms of complex 6 at rather different chemical shifts is evident in the 1H NMR 127 
spectra for compounds 51-MeBrF and 52-MeBrF. The initial spectra show a signal at a higher field that 128 
evolves into another one at a lower field as indicated below and in the Experimental part. For the 52-129 
MeBrH complex only the evolved signal at a lower field is observed; the absence of a fluoro substituent 130 
in the cyclometallated ligand, 3, produces a general high field shift in the imine resonances (as observed 131 
for both isomers of 52-MeBrH, which display signals at 7.92 and 7.71 ppm), and the high field imine 132 
signal is expected to overlap under the aromatic signals. Interestingly, for complex 51-FBrF a single 133 
reductively eliminated complex 6 is observed, showing the iminic proton signal at a higher field that is 134 
not seen to evolve in the lower field signal. For complexes 52-HBrH and 52-HBrF no reductively 135 
eliminated species 6 are observed in the 1H NMR spectra. 136 
The disappearance of the signals of compounds 6 (as a mixture or as a single species) is accompanied by 137 
the expected increase of a new signal due to seven-membered metallacycle compounds 7, characterised 138 
by a JH–Pt in the 120–130 Hz range. Evidently for complexes 52-HBrH and 52-HBrF a simple 139 
appearance of compounds 7 is observed, as stated above. As indicated in the previous paragraph, the two 140 
sets of signals of compounds 6 (Scheme 3) show a definite trend in their relative intensity; after the 141 
initial formation of the trans-Nimine/C isomer increasing quantities of the cis-Nimine/C form are 142 
observed (Fig. 2). The relatively fast evolution of these forms prevents isolation of these intermediates; 143 
nevertheless, the distinct JPt–H values observed for the imine proton, 44 Hz and 120–144 Hz for the 144 
trans- and cis-Nimine/C isomers allows unequivocal identification (Scheme 3). No other intermediates 145 
were observed, not even those corresponding to E–Z isomerisation of the imine group. After build up, 146 
complexes 6 in the cis-Nimine/C isomeric form disappear in favour of the final compound 7. 147 
As a comparison, it is interesting to indicate that for compounds of the same family where the 148 
dialkylsulfide ligands (L) have been replaced with a –CH2–CH2–NMe2 group attached to the imine 149 
nitrogen (thus forming a PtNimine/Namine chelate), the final oxidative addition on compounds of type 6 150 
has also been proved to take place through the cis-Nimine/C form after isomerisation of the kinetically 151 
preferred trans-Nimine/C isomer formed from the corresponding platinum(IV) compound and both 152 
isomers have been structurally characterised.17 153 
One should note that, given the fact that for 52-HBrH and 52-HBrF no accumulation of complexes of 154 
type 6 occurs, the reactions taking place after the rate limiting initial reductive elimination have to be 155 
relatively fast in this case. In the same respect, for complex 51-FBrF the build-up of species 6 in a 156 
cisNimine/C form does not occur (see Fig. 2 for the expected trend), indicating that the cis-61-FBrF → 157 
71-FBrF is faster than the trans-61-FBrF → cis-61-FBrF isomerisation reaction, which should be rate 158 
limiting in this case. Table 1 collects the nature of the rate limiting reactions observed according to 1H 159 
NMR spectroscopy. 160 
In view of these results, time-resolved monitoring of the UV-Vis spectral changes occurring in toluene 161 
solutions of compounds 5 was conducted at different temperatures to fully quantify the time-dependence 162 
observed. For compounds 51-MeBrF, 52-MeBrH and 52-MeBrF, a two-step sequence (Fig. S1, ESI†) 163 
was observed for the time span used, as expected from the above NMR data.14,15 The data collected in 164 
Table 1 correspond to the rate constants of the rate limiting process of formation of compound 7 from 165 
complex 6 in a cis-Nimine/Cform, as measured by 1H NMR spectroscopy. The values determined for 166 
ΔH‡, ΔS‡ and ΔV‡ are the first ones determined for the oxidative addition reaction leading to the 167 
formation of seven-membered metallacycles with monodentate ligands indicated in Scheme 3 (Fig. 3). 168 
For bidentate PtNimine/Namine systems some data are available,17 although comparison might be non-169 
significant due to the different requirements of the ligands. In the present study the values of the 170 
activation enthalpies are much lower (within the 65–87 range versus 105–140 for the PtNimine/Namine 171 
systems) and the activation entropies are clearly negative (close to zero for the PtNimine/Namine 172 
systems) while keeping the value of ΔV‡ at zero. Clearly the oxidative addition reaction leading from 173 
complex 6 (cis-Nimine/C) to 7, indicated in Scheme 3, proceeds via a better ordered transition state 174 
requiring less energy than that for the more encumbered bidentate PtNimine/Namine systems. The 175 
values are similar to those collected for the formation of complexes 5 from 1 + 3.21,24 The activation 176 
volumes should correspond to a compensation effect between a high degree of compression, due to the 177 
concerted nature of the oxidative addition, and an increase in bond distances, including the 178 
decoordination of the L ligand needed for the process.16,17,28–32 179 
For complexes 52-HBrF and 52-HBrH the data collected for the rate determining single step in Table 1 180 
(Fig. 4a) are very different, which is not surprising in view of the results indicated in the previous 181 
paragraphs and in the second column of the table.14,15 In this case it is the reductive elimination 182 
reaction step that has been quantified, showing rather high values of ΔH‡, practically zero values of ΔS‡ 183 
and positive volumes of activation (Fig. 4b). The latter is clearly due to the lengthening of the Pt–C 184 
distances due to reductive elimination, despite an increased ordering. The data are definitively in line 185 
with those observed for the reductive elimination occurring on the analogous PtNimine/Namine 186 
systems.17 It is clear that the presence of a chelate does not seem to affect the process in an important 187 
way; dissociation of the L or Namine ancillary ligands is not required according to the microreversibility 188 
principle.28–34 189 
Finally the data collected in Table 1 for compound 51-FBrF, where only species trans-61-FBrF has been 190 
detected by 1H NMR, show that the dominant rate determining step corresponds to the isomerisation 191 
reaction from trans-61-FBrF to cis-61-FBrF, as indicated above. The values collected for the activation 192 
parameters can thus be compared with the equivalent isomerisation occurring on the PtNimine/Namine 193 
analogous systems.17 In the present case the value of ΔH‡ is larger, while that of ΔS‡ is less negative; 194 
the value of ΔV‡ parallels that of the activation entropy. Clearly, in the present system decoordination of 195 
the dialkylsulfide ligand seems to be playing a more important role in the reaction than its back 196 
coordination, as was found for the amine back coordination on the PtNimine/Namine mentioned 197 
systems. Interestingly, by UV-Vis (a much more concentration-sensitive technique) a faster step is also 198 
detected, which is not observed by 1H NMR spectroscopy, that probably corresponds to the 5 → 6 199 
process, although its nature cannot be guaranteed. 200 
In this respect, the faster steps detected during the monitoring of the UV-Vis spectral changes of the 201 
toluene solution of compounds 51-MeBrF, 52-MeBrH and 52-MeBrF should correspond to the 202 
respective 6(trans-Nimine/C) → 6(cis-Nimine/C) isomerisation reactions, to the 5 → 6 reductive 203 
elimination reaction, or to a composite of both steps (see Fig. S1†). Table 2 collects the relevant data 204 
obtained as indicated in the Experimental section. For complex 51-FBrF, the measured step should 205 
correspond either to the reductive elimination to produce trans-61-FBrF or to the final oxidative addition 206 
reaction to produce compound 71-FBrF; data are also collected in Table 2. 207 
From the data collected in Table 1 it seems rather obvious that none of the processes involved in the 208 
values determined corresponds to the 6(trans-Nimine/C) → 6(cis-Nimine/C) isomerisation reactions, 209 
characterised by a negative value of ΔV‡. The reductive 5 → 6(trans-Nimine/C) step does not either 210 
seem to be the effective process measured, by comparison of the relevant data also collected in Table 1. 211 
Probably the measured values correspond to a mixture of both steps occurring at rather similar rates. 212 
This sort of unresolved behaviour has already been observed in some other related systems, although in 213 
some cases the choice of different temperature ranges has allowed for a comprehensive study.16,17 In 214 
the present case the existence of a follow up reaction (Table 1) has not allowed for such techniques and 215 




In summary, the comprehensive 1H NMR spectroscopy study of the 5 → 7 process, indicated in Scheme 220 
2, shows that this is a three step process involving an initial 5 → 6(trans-Nimine/C) reductive 221 
elimination step, followed by a 6(trans-Nimine/C) → 6 (cis-Nimine/C) isomerisation reaction, to finish 222 
up with a 6(cis-Nimine/C)) → 7 cycloplatination process via an oxidative addition/reductive elimination 223 
sequence (Scheme 3). Interestingly, while for the phenyl 52-HBrH and 52-HBrF derivatives the rate 224 
determining step corresponds to the reductive elimination 5 → 6(trans-Nimine/C) reaction, for the p-225 
tolyl 51-MeBrF, 52-MeBrH and 52-MeBrF the reactions are limited by the final 6(cis-Nimine/C) → 7 226 
oxidative addition step. For the p-fluoro 51- FBrF complex the trans-61-MeBrF → cis-61-MeBrF 227 
isomerisation, prior to the final oxidative addition, is the process limiting the reactivity of the system. 228 
The kinetic and thermal and pressure activation parameters measured for these limiting processes agree 229 
with the expected, as does the isomerisation sequence already established for similar PtNimine/Namine 230 
systems. Clearly the nature of the substituent at the para position of the ancillary aryl ligand (R) plays a 231 
decisive role during the process, as the X substituent has been proved to have in the five- versus seven-232 
membered cycloplatination reactions.16,17 Electron donating Me should slow-down any reductive 233 
elimination process, either that leading to the 6(cis-Nimine/C) complex, or that producing the final 234 
compound 7 by elimination of C6H5R (see Scheme 3); clearly the latter is the one more affected in this 235 
case. The electron withdrawing F hampers the dissociation of the ancillary L ligand in Pt(II) compound 236 
6 to undergo the 6(trans-Nimine/C) → 6(cis-Nimine/C) reaction. In the same respect, the differences 237 
between the SMe2 and SEt2 derivatives do not seem to be relevant for the rate-determining step, as seen 238 
for 51-MeBrF and 52-MeBrF in Table 1. The differences, if existing, should be appearing in the faster 239 
non-rate determining steps observed. 240 




Microanalyses were performed at the Centres Científics i Tecnològics (Universitat de Barcelona). NMR 245 
spectra were recorded at the Unitat de RMN d’Alt Camp de la Universitat de Barcelona using a 246 
Mercury-400 (1H, 400 MHz; 19F, 376.5 MHz) and referenced to SiMe4 (1H) or CFCl3 (19F). δ values 247 
are given in ppm and J values in Hz. Abbreviations used: s = singlet; d = doublet; t = triplet; m = 248 
multiplet; br = broad. 249 
 250 
Preparation of complexes 251 
Platinum compounds [Pt2(4-RC6H4)4(μ-SEt2)2] (1-Me, R = Me35 or 1-F, R = F12), [Pt(4-252 
RC6H4)2(SMe2)2] (2-Me, R = Me36 or 2-H, R = H37), ligands 2-X,6-FC6H3CHvNCH2P h (3-BrF, X 253 
= Br6 or 3-ClF, X = Cl38) and 2-BrC6H4CHvNCH2Ph (3-BrH)39 and the compound 254 
[PtBr{C6H4(C6H4)CHvNCH2Ph}SMe2] (72-HBrH)15 were prepared as reported elsewhere 255 
Compounds 7. Compounds [PtX{(4-RC6H3)(2-YC6H3) CHvNCH2Ph}L] (71-MeBrF: R = Me, X = 256 
Br, Y = F, L = SEt2; 71-MeClF: R = Me, X = Cl, Y = F, L = SEt2; 71-FBrF: R = F, X = Br, Y = F, L = 257 
SEt2; 71-FClF: R = F, X = Cl, Y = F, L = SEt2; 72-MeBrF: R = Me, X = Br, Y = F, L = SMe2; 72-258 
MeBrH: R = Me, X = Br, Y = H, L = SMe2; 72-HBrF: R = H, X = Br, Y = F, L = SMe2) were obtained 259 
after stirring under reflux for 6 hours a solution containing 0.090 g of compounds 1-Me (0.096 mmol) or 260 
1-F (0.095 mmol), or 50 mg of compounds 2-Me (0.100 mmol) or 2-H (0.105 mmol) and the equivalent 261 
amount of the corresponding ligand 3-BrF (56 mg for 71-MeBrF, 55 mg for 71-FBrF, 29 mg for 72-262 
MeBrF and 31 mg for 72-HBrF), 3-ClF (48 mg for 71-MeClF and 47 mg for 71-FClF) or 3-BrH (31 mg 263 
for 72-HBrF) in toluene. The solvent was evaporated and the residue was treated with diethyl ether. The 264 
white or light yellow solids were filtered and dried in a vacuum. Yield: 77 mg (60%) for 71-MeBrF; 72 265 
mg (61%) for 71-MeClF; 77 mg (61%) for 71-FBrF; 86 mg (72%) for 71-FClF; 54 mg (85%) for 72-266 
MeBrF; 43 mg (69%) for 72-MeBrH and 50 mg (76%) for 72-HBrF (Chart 1). 267 
[PtBr{(4-MeC6H3)(2-FC6H3)CHvNCH2Ph}SEt2] (71-MeBrF). 1H NMR (400 MHz, CDCl3), δ = 8.66 268 
(s, 3JH–Pt = 128.0, 1H, Hg), 7.45 (td, 3JH–H = 8.0, 4JH–F = 6.0, 1H, He), 7.30 (m, 1H), 7.22–7.21 (m, 269 
4H), 7.14 (d, 3JH–H = 7.6 Hz, 1H, Hd), 7.05 (t, 3JH–H = 3JH–F = 8.8, 1H, Hf ), 6.83 (d, 3JH–H = 7.6, 270 
1H, Hc), 6.70 (d, 3JH–H = 7.6, 1H, Hb), 6.24 (s, 3JH–Pt = 64.8, 1H, Ha), 5.69 (dd, 2JH–H = 12.8, 4JH–271 
H = 1.6, 1H, Hh), 5.03 (d, 2JH–H = 13.2, 1H, Hh), 3.08 (s, br, 1H, Hi), 2.67 (s, br, 2H, Hi), 2.38 (s, br, 272 
1H, Hi), 2.11 (s, 3H, Me), 1.28 (s, br, 3H, Hj), 0.98 (s, br, 3H, Hj). 19F NMR (376.5 MHz, CDCl3), δ 273 
(ppm): −115.05 (ddd, 3JF–H = 9.0, 4JF–H = 5.6, 5JF–H = 2.0). EA (calc. for C25H27BrFNPtS): C: 274 
45.21% (44.98%); H: 4.38% (4.08%); N: 2.32% (2.10%); S: 4.70% (4.80%). 275 
[PtCl{(4-MeC6H3)(2-FC6H3)CHvNCH2Ph}SEt2] (71-MeClF). 1H NMR (400 MHz, CDCl3), δ = 8.67 276 
(s, 3JH–Pt = 120.4, 1H, Hg), 7.45 (td, 3JH–H = 8.0, 4JH–F = 6.0, 1H, He), 7.29 (m, 1H), 7.24–7.18 (m, 277 
4H), 7.14 (d, 3JH–H = 7.6 Hz, 1H, Hd), 7.04 (t, 3JH–H = 3JH–F = 8.8, 1H, Hf ), 6.82 (d, 3JH–H = 7.6, 278 
1H, Hc), 6.69 (dd, 3JH–H = 7.6, 4JH–H = 1.2, 1H, Hb), 6.31 (s, 3JH–Pt = 54.8, 1H, Ha), 5.63 (dd, 2JH–279 
H = 13.2, 4JH–H = 2.0, 1H, Hh), 5.01 (d, 2JH–H = 13.2, 3JH–Pt = 43.2, 1H, Hh), 3.08 (s, br, 1H, Hi), 280 
2.62 (s, br, 2H, Hi), 2.35 (s, br, 1H, Hi), 2.11 (s, 3H, Me), 1.25 (s, br, 3H, Hj), 0.97 (s, br, 3H, Hj). 19F 281 
NMR (376.5 MHz, CDCl3), δ (ppm): −115.07 (ddd, 3JF–H = 8.6, 4JF–H = 6.0, 5JF–H = 2.0). EA (calc. 282 
for C25H27ClFNPtS·0.5H2O): C: 47.50% (47.50%); H: 4.43% (4.46%); N: 2.46% (2.22%); S: 4.87% 283 
(5.07%).  284 
[PtBr{(4-FC6H3)(2-FC6H3)CHvNCH2Ph}SEt2] (71-FBrF). 1H NMR (400 MHz, CDCl3), δ = 8.61 (s, 285 
3JH–Pt = 120.0, 1H, Hg), 7.39 (td, 3JH–H = 8.0, 4JH–F = 6.0, 1H, He), 7.25 (m, 1H), 7.17–7.13 (m, 286 
4H), 7.05 (d, 3JH–H = 8.0 Hz, 1H, Hd), 7.04 (t, 3JH–H = 3JH–F = 8.8, 1H, Hf ), 6.83 (t, 3JH–H = 4JH–287 
F = 6.4, 1H, Hc), 6.52 (t, 3JH–H = 3JH–F = 8.4, 1H, Hb), 6.01 (d, 3JH–F = 9.2, 3JH–Pt = 59.2, 1H, Ha), 288 
5.62 (d, 2JH–H = 12.8, 1H, Hh), 4.94 (d, 2JH–H = 12.8, 3JH–Pt = 58.4, 1H, Hh), 3.00 (s, br, 1H, Hi), 289 
2.62 (s, br, 2H, Hi), 2.38 (s, br, 1H, Hi), 1.13 (s, br, 3H, Hj), 0.88 (s, br, 3H, Hj). 19F NMR (376.5 MHz, 290 
CDCl3), δ (ppm): −114.73 (m), −116.94 (m). EA (calc. for C24H24BrF2NPtS): C: 42.92% (42.93%); 291 
H: 3.72% (3.60%); N: 2.20% (2.09%); S: 4.47% (4.77%). 292 
[PtCl{(4-FC6H3)(2-FC6H3)CHvNCH2Ph}SEt2] (71-FClF). 1H NMR (400 MHz, CDCl3), δ = 8.64 (s, 293 
3JH–Pt = 120.0, 1H, Hg), 7.40 (td, 3JH–H = 8.0, 4JH–F = 5.4, 1H, He), 7.25 (m, 1H), 7.24–7.12 (m, 294 
4H), 7.05 (d, 3JH–H = 7.6 Hz, 1H, Hd), 7.01 (t, 3JH–H = 3JH–F = 8.8, 1H,Hf ), 6.83 (t, 3JH–H = 4JH–295 
F = 6.4, 1H,Hc), 6.52 (t, 3JH–H = 3JH–F = 8.4, 1H, Hb), 6.09 (d, 3JH–F = 9.6, 3JH–Pt = 54.8, 1H, Ha), 296 
5.55 (d, 2JH–H = 12.8, 1H, Hh), 4.92 (d, 2JH–H = 12.0, 3JH–Pt = 50.4, 1H, Hh), 3.01 (s, br, 1H, Hi), 297 
2.55 (s, br, 2H, Hi), 2.32 (s, br, 1H, Hi), 1.19 (s, br, 3H, Hj), 0.90 (s, br, 3H, Hj). 19F NMR (376.5 MHz, 298 
CDCl3), δ (ppm): −114.73 (m), −117.13 (m). EA (calc. for C24H24ClF2NPtS): C: 45.20% (45.97%); H: 299 
3.84% (3.86%); N: 2.37% (2.23%); S: 4.63% (5.11%). 300 
[PtBr{(4-MeC6H3)(2-FC6H3)CHvNCH2Ph}SMe2] (72-MeBrF). 1H NMR (400 MHz, CDCl3), δ = 301 
8.53 (s, 3JH–Pt = 120.0, 1H, Hg), 7.40 (td, 3JH–H = 8.0, 4JH–F = 6.0, 1H, He), 7.22 (m, 1H), 7.18–7.09 302 
(m, 5H), 6.99 (t, 3JH–H = 3JH–F = 8.0, 1H, Hf ), 6.78 (d, 3JH–H = 8.0, 1H, Hc), 6.65 (d, 3JH–H = 8.0, 303 
1H, Hb), 6.29 (s, 3JH–Pt = 56.0, 1H, Ha), 5.60 (dd, 2JH–H = 12.0, 4JH–H = 2.0, 1H, Hh), 5.01 (d, 2JH–304 
H = 12.0, 3JH–Pt = 56.0, 1H, Hh), 2.33 (s, br, 3H, Hi), 1.97 (s, br, 3H, Hi). 19F NMR (376.5 MHz, 305 
CDCl3), δ (ppm): −114.81 (ddd, 3JF–H = 9.2, 4JF–H = 6.0, 5JF–H = 2.6). EA (calc. for 306 
C23H23BrFNPtS·1.5H2O): C: 41.30% (41.45%); H: 3.53% (3.93%); N: 2.26% (2.10%); S: 4.42% 307 
(4.81%). 308 
[PtBr{(4-MeC6H3)(C6H4)CHvNCH2Ph}SMe2] (72-MeBrH). 1H NMR (400 MHz, CDCl3), δ = 8.44 309 
(s, 3JH–Pt = 124.0, 1H, Hg), 7.44–7.40 (m, 1H), 7.33–7.21 (m, 4H), 7.18–7.12 (m, 4H), 6.78 (d, 3JH–H 310 
= 8.0, 1H, Hc), 6.66 (d, 3JH–H = 8.0, 1H, Hb), 6.32 (s, 3JH–Pt = 56.0, 1H, Ha), 5.58 (dd, 2JH–H = 12.0, 311 
4JH–H = 2.0, 1H, Hh), 4.98 (d, 2JH–H = 12.0, 3JH–Pt = 52.0, 1H, Hh), 2.28 (s, br, 3H, Hi), 1.97 (s, br, 312 
3H, Hi). EA (calc. for C23H24BrNPtS·H2O): C: 43.40% (43.20%); H: 3.87% (4.10%); N: 2.38% 313 
(2.19%); S: 4.72% (5.01%). 314 
[PtBr{(C6H4)(2-FC6H3)CHvNCH2Ph}SMe2] (72-HBrF). 1H NMR (400 MHz, CDCl3), δ = 8.52 (s, 315 
3JH–Pt = 120.0, 1H, Hg), 7.45–7.39 (m, 1H), 7.21–7.20 (m, 2H), 7.17–7.11 (m, 4H), 7.02 (t, 3JH–H = 316 
8.0, 1H), 6.90 (td, 3JH–H = 8.0; 4JH–H = 1.6, 1H), 6.86 (td, 3JH–H = 7.2; 4JH–H = 1.2, 1H), 6.73 (td, 317 
3JH–H = 7.2; 4JH–H = 1.6, 1H), 6.60 (dd, 3JH–H = 7.6; 4JH–H = 1.2, 3JH–Pt = 52.0, 1H, Ha), 5.57 318 
(dd, 2JH–H = 13.6, 4JH–H = 2.0, 1H, Hh), 5.06 (d, 2JH–H = 13.6, 3JH–Pt = 49.2, 1H, Hh), 2.31 (s, br, 319 
3H, Hi), 2.00 (s, br, 3H, Hi). 19F NMR (376.5 MHz, CDCl3), δ (ppm): −114.84 (ddd, 3JF–H = 9.8, 320 
4JF–H = 5.6, 5JF–H = 2.2). EA (calc. for C22H21BrFNPtS·H2O): C: 40.77% (41.06%); H: 3.35% 321 
(3.60%); N: 2.28% (2.18%); S: 4.72% (4.98%). 322 
Compounds 5. Compounds [PtX(4-RC6H4)2(2-YC6H3CHv NCH2Ph)L] (51-MeBrF: R = Me, X = Br, 323 
Y = F, L = SEt2; 51-FBrF: R = F, X = Br, Y = F, L = SEt2; 52-MeBrF: R = Me, X = Br, Y = F, L = 324 
SMe2; 52-MeBrH: R = Me, X = Br, Y = H, L = SMe2; 52-HBrF: R = H, X = Br, Y = F, L = SMe2 and 325 
52-HBrH: R = H, X = Br, Y = H, L = SMe2) were characterised by 1H NMR spectra. 10 mg of the 326 
corresponding platinum precursor 1-Me, 1-F, 2-Me or 2-H and the equivalent amount of the 327 
corresponding ligand 3-BrF or 3-BrH were mixed at 25 °C in a NMR tube and allowed to react for the 328 
reaction times stated below. 51-MeBrF: reaction time, 30 min; 1H NMR (400 MHz, CDCl3), δ = 8.26 329 
(s, 3JH–Pt = 44, 1H, CHvN) (major isomer 2 : 1); 8.06 (s, 3JH–Pt = 44, 1H, CHvN) (minor isomer). 51-330 
FBrF: reaction time, 30 min; 1H NMR (400 MHz, CDCl3), δ = 8.34 (s, 3JH–Pt = 44, 1H, CHvN), 5.47 331 
(m, 2H, CH2Ph), 1.06 (t, 3JH–Pt = 16.0, 6H, SCH2CH3) (major isomer 1.6 : 1); 7.97 (s, 3JH–Pt = 44, 332 
1H, CHvN), 5.05 (m, 2H, CH2Ph), 1.29 (t, 3JH–Pt = 16.0, 6H, SCH2CH3) (minor isomer). 52-MeBrF: 333 
reaction time, 180 min; 1H NMR (400 MHz, CDCl3), δ = 8.29 (s, 3JH–Pt = 44, 1H, CHvN), {5.65 (dd, 334 
2JH–H = 17.2, 4JH–H = 1.6, 1H), 5.52 (dd, 2JH–H = 17.2, 4JH–H = 1.6, 1H), CH2Ph}, 2.14 (s, 3JH–Pt 335 
= 12.0, 6H, SMe2) (major isomer 2 : 1); δ = 8.05 (s, 3JH–Pt = 44, 1H, CHvN), {5.54 (dd, 2JH–H = 17.0, 336 
4JH–H = 1.6, 1H), 5.43 (dd, 2JH–H = 17.0, 4JH–H = 1.6, 1H), CH2Ph}, 2.06 (s, 3JH–Pt = 12.0, 6H, 337 
SMe2) (minor isomer). 52-MeBrH: reaction time, 180 min; 1H NMR (400 MHz, CDCl3), δ = 7.92 (s, 338 
3JH–Pt = 44, 1H, CHvN), {5.53 (dd, 2JH–H = 17.2, 4JH–H = 1.6, 1H), 5.42 (dd, 2JH–H = 17.2, 4JH–H 339 
= 1.6, 1H), CH2Ph}, 1.95 (s, 3JH–Pt = 12.0, 6H, SMe2) (major isomer 2 : 1); δ = 7.71 (s, 3JH–Pt = 48, 340 
1H, CHvN); {5.45 (dd, 2JH–H = 17.0, 4JH–H = 1.6, 1H), 5.43 (dd, 2JH–H = 17.0, 4JH–H = 1.6, 1H), 341 
CH2Ph}, 2.07 (s, 3JH–Pt = 12.0, 6H, SMe2) (minor isomer). 52-HBrF: reaction time, 30 min; 1H NMR 342 
(400 MHz, CDCl3), δ = 8.29 (s, 3JH–Pt = 44, 1H, CHvN), {5.58 (dd, 2JH–H = 16.0, 4JH–H = 2.0, 1H), 343 
5.44 (dd, 2JH–H = 16.0, 4JH–H = 2.0, 1H), CH2Ph}, 1.99 (s, 3JH–Pt = 12.0, 6H, SMe2) (major isomer 344 
2 : 1); δ = 8.06 (s, 3JH–Pt = 48, 1H, CHvN); {5.48 (dd, 2JH–H = 16.0, 4JH–H = 2.0, 1H), 5.37 (dd, 345 
2JH–H = 16.0, 4JH–H = 2.0, 1H), CH2Ph}, 2.07 (s, 3JH–Pt = 12.0, 6H, SMe2) (minor isomer). 52-346 
HBrH: reaction time, 90 min; 1H NMR (400 MHz, CDCl3), δ = 7.95 (s, 3JH–Pt = 48, 1H, CHvN), 347 
{5.44 (dd, 2JH–H = 17.0, 4JH–H = 2.0, 1H), 5.42 (dd, 2JH–H = 17.0, 4JH–H = 2.0, 1H), CH2Ph}, 1.95 348 
(s, 3JH–Pt = 12.0, 6H, SMe2) (major isomer 3.8 : 1); δ = 7.72 (s, 3JH–Pt = 44, 1H, CHvN), {5.47 (dd, 349 
2JH–H = 17.0, 4JH–H = 2.0, 1H), 5.36 (dd, 2JH–H = 17.0, 4JH–H = 2.0, 1H), CH2Ph}, 2.07 (s, 3JH–Pt 350 
= 12.0, 6H, SMe2) (minor isomer). 351 
Compounds 6. Compounds [PtX(4-RC6H4)(4-RC6H4–2- YC6H3CHvNCH2Ph)L] (61-MeBrF: R = 352 
Me, X = Br, Y = F, L = SEt2; 61-FBrF: R = F, X = Br, Y = F, L = SEt2; 62-MeBrF: R = Me, X = Br, Y 353 
= F, L = SMe2 and 62-MeBrH: R = Me, X = Br, Y = H, L = SMe2) were characterised by 1H NMR 354 
spectra. Solutions containing compounds 5 (see above) were concentrated to dryness, and the residues 355 
were washed with diethyl ether in order to remove excess of imine and dialkylsulfide ligands, and dried 356 
in vacuo. The obtained residues (crude compounds 5) were dissolved at 25 °C in a NMR tube and the 357 
reaction was monitored under the conditions stated below. 61-MeBrF: reaction time, 20–120 min, 358 
temperature 40 °C; 1H NMR (400 MHz, CDCl3), δ = 7.85 (s, 3JH–Pt = 44) (trans-Nimine/C); 8.56 (s, 359 
3JH–Pt = 144) (cis-Nimine/C) (initial ratio ca. 1 : 1). 61-FBrF: reaction time, 40–80 min, temperature 25 360 
°C; 1H NMR (400 MHz, CDCl3), δ = 8.10 (s, 3JH–Pt = 44) (trans-Nimine/C). 62-MeBrF: reaction time, 361 
10–300 min, temperature 25 °C; 1H NMR (400 MHz, CDCl3), δ = 7.85 (s, 3JH–Pt = 44) (trans-362 
Nimine/C); 8.48 (s, 3JH–Pt = 120) (cis-Nimine/C) (initial ratio ca. 1 : 1). 62-MeBrH: reaction time, 20–363 
400 min, temperature 30 °C; 1H NMR (400 MHz, CDCl3), δ = 8.35 (s, 3JH–Pt = 124) (cis-Nimine/C). 364 
 365 
X-ray structure analysis 366 
A crystal of approximate dimensions 0.074 mm × 0.105 mm × 0.254 mm was selected and intensity data 367 
were measured on a D8 Venture system equipped with a multilayer monochromator and a Mo 368 
microfocus. The structure was solved using the Bruker SHELXTL Software Package, and refined using 369 
SHELXL.40 Further details are given in Table 3 and Fig. 1. 370 
 371 
Kinetics 372 
The kinetic profiles for the reactions were followed by UV-Vis spectroscopy in the 700–300 nm range 373 
on HP8452A or Cary50 instruments equipped with thermostated multicell transports. The observed rate 374 
constants were derived from absorbance versus time traces at the wavelengths where a maximum 375 
increase and/or decrease of absorbance was observed. For the reactions carried out at varying pressure 376 
the previously described pillbox cell and pressurising system41–44 were used and final treatment of data 377 
was the same as described before. The calculation of the observed rate constants from the absorbance 378 
versus time monitoring of reactions was carried out using the SPECFIT or ReactLab softwares;45,46 379 
typical errors of these values are within the 10–20% margin. The general kinetic technique is that 380 
previously described.15,20,47 Table S1† collects all the obtained kobs values for all the systems studied 381 
as a function of the starting complex, process studied, pressure and temperature. All post-run fittings 382 
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.463 
Legends to figures 464 
 465 
Figure 1 Molecular structure of compound 71-MeBrF. Selected bond lengths (Å) and angles (°) with 466 
estimated standard deviations are: Pt(1)–C (1): 2.001(3); Pt(1)–N(1): 2.028(2); Pt(1)–S(1): 2.2701(6); 467 
Pt(1)–N(1): 2.028 (2); Pt(1)–Br(1): 2.5456(3); C(1)–Pt(1)–N(1): 86.01(9); C(1)–Pt(1)–S(1): 88.90(7); 468 
N(1)–Pt(1)–Br(1): 91.04(6); S(1)–Pt(1)–Br(1): 94.268(18). 469 
 470 
Figure 2. Evolution of the 1H NMR spectra (imine region) of a CDCl3 solution of compound 51MeBrF 471 
at 40 °C. (a) 20 minutes; (b) 40 minutes; (c) 60 minutes; (d) 80 minutes; (e) 120 minutes. 472 
 473 
Figure 3 Eyring and ln k versus P plots of the rate determining step observed in the 5 → 7 reaction in 474 
the 52-MeBrH (●, 54 °C) and 52-MeBrF (▴, 62 °C) systems. 475 
 476 
Fig. 4 (a) Single step UV-Vis spectral changes observed in a 5 × 10−4 M toluene solution of 52-HBrF 477 
(40 °C 4.5 hours). (b) Eyring and ln k versus P plots of the rate determining step observed in the 5 → 7 478 
reaction in the 52-HBrF (□, 45 °C) and 52-HBrH (○, data from ref. 14) systems. 479 
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Table 1. Summary of the kinetic and activation parameters determined for the rate determining step 519 






  526 
Table 2 Summary of the kinetic and activation parameters determined for the faster step measured 527 
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Table 3 Crystallographic and refinement data for compound 71-MeBrF 535 
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